CliffBio
small molecule

ALEVE-D SINUS & COLD

NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameALEVE-D SINUS & COLD
Active ingredientNAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
Strength220MG;120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 1999
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.